Response of high-risk of recurrence/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy.
第一作者:
L,Lima
第一单位:
1] Experimental Pathology and Therapeutics Group, Portuguese Institute of Oncology, Porto, Portugal [2] Institute of Biomedical Sciences of Abel Salazar, University of Porto, Porto, Portugal [3] Nucleo de Investigação em Farmácia-Centro de Investigação em Saúde e Ambiente (CISA), Health School of the Polytechnic Institute of Porto, Porto, Portugal [4] LPCC, Research Department-Portuguese League Against Cancer (NRNorte), Porto, Portugal.
作者:
医学主题词
老年人(Aged);抗原, 肿瘤相关, 碳水化合物(Antigens, Tumor-Associated, Carbohydrate);卡介苗(BCG Vaccine);细胞黏附(Cell Adhesion);细胞系, 肿瘤(Cell Line, Tumor);队列研究(Cohort Studies);疾病恶化(Disease Progression);无病生存(Disease-Free Survival);女(雌)性(Female);人类(Humans);男(雄)性(Male);中年人(Middle Aged);黏蛋白类(Mucins);多元分析(Multivariate Analysis);肿瘤复发, 局部(Neoplasm Recurrence, Local);回顾性研究(Retrospective Studies);危险因素(Risk Factors);治疗结果(Treatment Outcome);膀胱肿瘤(Urinary Bladder Neoplasms)
DOI
10.1038/bjc.2013.571
PMID
24064971
发布时间
2022-03-11
- 浏览17
British journal of cancer
2106-14页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



